Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Sable SB, Posey JE, Scriba TJ.

Clin Microbiol Rev. 2019 Oct 30;33(1). pii: e00100-19. doi: 10.1128/CMR.00100-19. Print 2019 Dec 18. Review.

PMID:
31666281
2.

Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis.

Nandakumar S, Kannanganat S, Dobos KM, Lucas M, Spencer JS, Amara RR, Plikaytis BB, Posey JE, Sable SB.

Sci Rep. 2016 May 13;6:25837. doi: 10.1038/srep25837.

3.

Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.

Nandakumar S, Kannanganat S, Posey JE, Amara RR, Sable SB.

PLoS One. 2014 Nov 24;9(11):e113951. doi: 10.1371/journal.pone.0113951. eCollection 2014.

4.

O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection.

Nandakumar S, Kannanganat S, Dobos KM, Lucas M, Spencer JS, Fang S, McDonald MA, Pohl J, Birkness K, Chamcha V, Ramirez MV, Plikaytis BB, Posey JE, Amara RR, Sable SB.

PLoS Pathog. 2013;9(10):e1003705. doi: 10.1371/journal.ppat.1003705. Epub 2013 Oct 10.

5.

Programmed death 1 lives up to its reputation in active tuberculosis.

Sable SB.

J Infect Dis. 2013 Aug 15;208(4):541-3. doi: 10.1093/infdis/jit211. Epub 2013 May 9. No abstract available.

6.

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.

Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, Shinnick TM.

PLoS One. 2011;6(7):e22718. doi: 10.1371/journal.pone.0022718. Epub 2011 Jul 25.

7.

Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin.

Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB.

Tuberculosis (Edinb). 2011 Jul;91(4):314-21. doi: 10.1016/j.tube.2011.03.003. Epub 2011 Apr 8.

PMID:
21482189
8.

Bacillus Calmette-Guérin vaccination using a microneedle patch.

Hiraishi Y, Nandakumar S, Choi SO, Lee JW, Kim YC, Posey JE, Sable SB, Prausnitz MR.

Vaccine. 2011 Mar 21;29(14):2626-36. doi: 10.1016/j.vaccine.2011.01.042. Epub 2011 Jan 28.

9.

Nanobead-based interventions for the treatment and prevention of tuberculosis.

Griffiths G, Nyström B, Sable SB, Khuller GK.

Nat Rev Microbiol. 2010 Nov;8(11):827-34. doi: 10.1038/nrmicro2437. Epub 2010 Oct 12. Review.

PMID:
20938454
10.

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.

Kalra M, Grover A, Mehta N, Singh J, Kaur J, Sable SB, Behera D, Sharma P, Verma I, Khuller GK.

Clin Immunol. 2007 Nov;125(2):173-83. Epub 2007 Sep 4.

PMID:
17766185
11.

Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.

Sable SB, Kalra M, Verma I, Khuller GK.

Clin Immunol. 2007 Mar;122(3):239-51. Epub 2007 Jan 5. Review.

PMID:
17208519
12.

An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection.

Birkness KA, Guarner J, Sable SB, Tripp RA, Kellar KL, Bartlett J, Quinn FD.

Immunol Cell Biol. 2007 Feb-Mar;85(2):160-8. Epub 2007 Jan 2.

PMID:
17199112
13.

Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.

Sable SB, Plikaytis BB, Shinnick TM.

Vaccine. 2007 Feb 19;25(9):1553-66. Epub 2006 Nov 15. Review.

PMID:
17166640
14.

Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins.

Sable SB, Goyal D, Verma I, Behera D, Khuller GK.

Eur Respir J. 2007 Feb;29(2):337-46. Epub 2006 Nov 1.

15.
16.

Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.

Giri PK, Sable SB, Verma I, Khuller GK.

FEMS Immunol Med Microbiol. 2005 Jul 1;45(1):87-93. Epub 2005 Mar 18.

17.
18.

Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.

Sable SB, Kumar R, Kalra M, Verma I, Khuller GK, Dobos K, Belisle JT.

Infect Immun. 2005 Jun;73(6):3547-58. Erratum in: Infect Immun. 2005 Dec;73(12):8456.

19.

Human immune recognition-based multicomponent subunit vaccines against tuberculosis.

Sable SB, Verma I, Behera D, Khuller GK.

Eur Respir J. 2005 May;25(5):902-10.

Supplemental Content

Loading ...
Support Center